FMP

FMP

Enter

CNSP - CNS Pharmaceuticals,...

photo-url-https://images.financialmodelingprep.com/symbol/CNSP.png

CNS Pharmaceuticals, Inc.

CNSP

NASDAQ

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, engages in the development of anti-cancer drug candidates for the treatment of brain and central nervous system tumors. The company's lead drug candidate is Berubicin, an anthracycline that is in Phase I and II clinical trials that is used for the treatment of glioblastoma multiforme. It has license agreements with Houston Pharmaceuticals, Inc. and The University of Texas M.D. Anderson Cancer Center, as well as Animal Life Sciences, LLC; and a development agreement with WPD Pharmaceuticals Inc., as well as a collaboration agreement with Reata Pharmaceuticals, Inc. The company was incorporated in 2017 and is based in Houston, Texas.

0.106 USD

0.0037 (3.5%)

CNSP Financial Statements

Year

2023

2022

2021

2020

Total Revenue

0

0

0

0

Cost of Revenue

4.13k

11.76k

13.07k

11.1k

Gross Profit

-4.13k

-11.76k

-13.07k

-11.1k

Operating Expenses

18.87M

15.27M

14.03M

9.45M

Research and Development

14.1M

9.3M

9.35M

5.06M

Selling, General & Administrative Expenses

4.77M

5.97M

4.68M

4.39M

Selling & Marketing Expenses

0

0

0

0

General & Administrative Expenses

4.77M

5.97M

4.68M

4.39M

Other Expenses

0

0

0

0

Operating Income

-18.87M

-15.27M

-14.03M

-9.45M

Total Other Income/Expenses Net

13.88k

-7.03k

-9.29k

-3.26k

Income Before Tax

-18.85M

-15.27M

-14.04M

-9.46M

Income Tax

0

7.03k

9.29k

3.26k

Net Income

-18.85M

-15.27M

-14.5M

-9.46M

Basic EPS

-251.35

-560.83

-852.66

-859.81

EPS Diluted

-250.19

-560.83

-825.04

-853.68

Basic Average Shares

75k

27.23M

17M

11M

Diluted Average Shares

75.35k

27.23M

17.57M

11.08M

EBITDA

-18.86M

-15.26M

-14.47M

-9.44M

Retained Earning Schedule

Year

2023

2022

2021

2020

Retained Earnings (Previous Year)

-50.72M

-34.98M

-20.95M

-11.49M

Net Income

-18.85M

-15.27M

-14.5M

-9.46M

Stock Repurchases

0

0

0

0

Dividend Paid

0

0

0

0

Retained Earnings

-69.57M

-50.72M

-34.98M

-20.95M

Other Distributions

-18.85M

-15.73M

-14.04M

-9.46M

PPE Schedule

Year

2023

2022

2021

2020

Gross PPE

4.93k

5.66k

16.11k

23.43k

Annual Depreciation

4.13k

11.76k

13.07k

11.1k

Capital Expenditure

-3.9k

-4.42k

-5.75k

-17.95k

Net PPE

4.7k

-1.67k

8.79k

30.28k

Intangible and Goodwill Schedule

Year

2023

2022

2021

2020

Acquisitions and Adjustments

0

0

0

0

Goodwill (Previous Year)

0

0

0

0

Goodwill

0

0

0

0

All figures are in USD.

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep